Litigation costs pour cold water on J&J’s finances

Johnson & Johnson posted a loss in the first three months of the year as it booked a massive $6.9 billion charge related to its recently-agreed proposal to settle clai

J&J gets Stelara okay in Europe for ulcerative colitis